Resources

• Technical Specifications

References

1. Cartron G, Dacheux L, Salles G, Solal-Celigny P, Bardos P, Colombat P and Watier H. 2002. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgRIIIa gene. Blood, 99: 754-758.
2. Weng W-K and Levy R. 2003. Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma. Journal of Clinical Oncology, 21(21): 3940-3947.
3. Dall’Ozzo S, Tartas S, Paintaud G, Cartron G, Colombat P, Bardos P, Watier H, and Thibault G. 2004. Cancer Research, 64:4664-4669.

Links

National Cancer Institute
www.cancer.gov

American Cancer Society
www.cancer.org

Rituxan® Product Information
www.rituxan.com

1-877-2-PGXHEALTH (877-274-9432)